Seres Therapeutics, Inc. Common Stock MCRB
HEALTHCARE · BIOTECHNOLOGYi
Market dataready · fetched 2026-11-11T15:19:48.978Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2027-01-15
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T15:19:29.603269906Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-11T15:19:48.068743+00:00
Seres Therapeutics, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 38.94 | 427.0% | 2547.8% | |||
| 25Δ | ||||||
| 30Δ | ||||||
| 35Δ | 2.74 | 359.8% | 41.3% | |||
| 40Δ | 3.51 | 352.6% | 37.1% | |||
| 45Δ | 4.28 | 345.4% | 33.0% | |||
| 50Δ | 5.05 | 338.3% | 28.8% | |||
| 55Δ | 5.82 | 331.1% | 24.6% | |||
| 60Δ | ||||||
| 65Δ | ||||||
| 70Δ | ||||||
| 75Δ | ||||||
| 80Δ | ||||||
20Δ
- Pseudo strike
- 38.94
- IV
- 427.0%
- B/E move
- 2547.8%
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.74
- IV
- 359.8%
- B/E move
- 41.3%
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.51
- IV
- 352.6%
- B/E move
- 37.1%
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 4.28
- IV
- 345.4%
- B/E move
- 33.0%
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 5.05
- IV
- 338.3%
- B/E move
- 28.8%
55Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 5.82
- IV
- 331.1%
- B/E move
- 24.6%
60Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
Options history
No recorded observations
Biotechnology
MDGL
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of…
More →MDWD
MediWound Ltd., a biopharmaceutical company, develops, manufactures and markets new and biotherapeutic solutions for tissue repair and regeneration. The company is headquartered…
More →MDXG
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company is headquartered in Marietta, Georgia.
More →MESO
Mesoblast Limited, a biopharmaceutical company, develops and markets allogeneic cellular drugs. The company is headquartered in Melbourne, Australia.
More →MGNX
Description unavailable
More →MGTX
Description unavailable
More →